Antibody and related biologic therapeutics present unique intellectual property (IP) challenges throughout discovery, development, and commercialization. This online workshop will bring together IP attorneys and industry experts from Haynes Boone, Wilson Sonsini, Morgan Lewis, Morrison Foerster, and Amgen to discuss practical strategies, emerging legal issues, and real-world case studies. Attendees will gain insights into protecting innovation, managing IP risks, and navigating an evolving legal landscape shaped by advances in biologics and AI.

Topics include:

• Patentability of antibody and related biologics
• Freedom to operate (FTO) around the use of antibody components
• AI's impact on intellectual property for antibody therapeutics
• Patent term extension and data exclusivity